|
TaqI B CETP genotypes in various complications of T2DM |
|||
| CLINICAL COMPLICATION (NO. OF PATIENTS) |
GENOTYPE (T2DM PATIENT NO. WITH COMPLICATION/WITHOUT COMPLICATION) |
P-VALUE |
OR (95% CI) |
|
|
|||
| Nephropathy (29) |
B1B1 (8/24) |
0.891 |
0.937 (0.365–2.403) |
| B1B2 (15/42) |
0.917 |
1.046 (0.449–2.437) |
|
| B2B2 (6/17) |
0.981 |
1.013(0.356–2.879) |
|
|
|
|||
| Neuropathy (12) |
B1B1 (4/24) |
0.744 |
1.229 (0.338–4.468) |
| B1B2 (5/42) |
0.563 |
0.697 (0.205–2.375) |
|
| B2B2 (3/17) |
0.712 |
1.294 (0.316–5.307) |
|
|
|
|||
| Retinopathy (9) |
B1B1 (3/24) |
0.719 |
1.229 (0.284–5.319) |
| B1B2 (4/42) |
1.000 |
0.781 (0.196–3.115) |
|
| B2B2(2/17) |
1.000 |
1.109 (0.211–5.830) |
|
|
|
|||
| Hypertension (29) |
B1B1 (1/17) |
0.038 |
0.139 (0.018–1.093) |
| B1B2 (22/42) |
0.018 |
3.068 (1.183–7.958) |
|
| B2B2 (6/24) |
0.389 |
0.641 (0.232–1.772) |
|
Dixit et al. BMC Endocrine Disorders 2005 5:7 doi:10.1186/1472-6823-5-7 |
|||